| June 30, 2005 |
Forbes Medi-Tech Announces FM-VP4 Study Results to be Presented at AAPS Conference |
| June 27, 2005 |
Forbes Medi-Tech Completes FM-VP4 Toxicity Study |
| May 16, 2005 |
Forbes Medi-Tech announces Financial Results for the Quarter ended March 31, 2005 |
| May 02, 2005 |
Forbes Medi-Tech Announces Product Launch with Kesko of Finland |
| March 30, 2005 |
Forbes Medi-Tech Announces Financial Results for the 4th Quarter and Year Ended December 31, 2004 |
| March 29, 2005 |
Forbes Medi-Tech Announces Timing of Year End Financial Results and AGM |
| March 02, 2005 |
Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups |
| February 01, 2005 |
Forbes Medi-Tech Initiates Toxicity Study on FM-VP4 to Support US Phase II trial for Cholesterol-Lowering Drug |
| January 12, 2005 |
Forbes Medi-Tech Provides 2005 Revenue Guidance |
| December 01, 2004 |
Forbes Medi-Tech's Manufacturing Facility Expanded to 1500 Metric Tonnes |
| November 29, 2004 |
Forbes Medi-Tech Expands Reducol(tm) Business into Scandinavia with Scanvit Ltd, Finland |
| November 22, 2004 |
Forbes Medi-Tech Signs International Reducol (tm) Sales and Licensing Agreement |
| November 19, 2004 |
Forbes Medi-Tech Appoints Dr. Steven Nissen to Chairman of Medical & Scientific Advisory Board |
| November 15, 2004 |
Forbes Medi-Tech Announces Financial Results for the Third Quarter ended September 30, 2004 |
| November 12, 2004 |
Forbes Medi-Tech Receives Final Approval for Reducol(tm) Sales in the European Union |
| November 11, 2004 |
Forbes Medi-Tech Announces Timing of Third Quarter Financial Results |
| October 05, 2004 |
Company Appoints New Chief Financial Officer |
| October 01, 2004 |
Company Completes Regulatory Filing |
| September 08, 2004 |
Forbes Medi-Tech Announces US$24.4 Million in Sterols Sales Agreement |
| August 12, 2004 |
Forbes Medi-Tech Announces Financial Results for the Second Quarter ended June 30, 2004 |
| July 29, 2004 |
Forbes Medi-Tech Announces the Addition of Two Novel Cholesterol Absorption Inhibitors to its Drug Development Pipeline |
| July 08, 2004 |
Forbes Medi-Tech Clears Key Regulatory Hurdle for Reducol(tm) Approval in Europe |
| July 06, 2004 |
Forbes Medi-Tech Announces FM-VP4 Development Plan |
| June 29, 2004 |
Forbes Medi-Tech Inc. President & CEO on ROB TV |
| June 29, 2004 |
Forbes Medi-Tech Announces Increase in Revenue Guidance Based on Growth in Sterol Sales |
